Exagen Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Exagen Inc. on April 23, 2026, reporting events that occurred on April 17, 2026. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market under the symbol "XGN".
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
On April 17, 2026, Ana Hooker resigned as a member of the Board of Directors, effective immediately. Ms. Hooker served on the Audit Committee and chaired the Nominating and Corporate Governance Committee. Consequently, the Board size was reduced from eight (8) members to seven (7) members. The Company stated that the resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
Outlook and Management Commentary
Following the resignation, the Board committees were reconstituted as follows:
- Audit Committee: Paul Kim (Chairman, Financial Expert), Scott D. Kahn, Ph.D., Bruce C. Robertson, Ph.D.
- Compensation Committee: Tina S. Nova, Ph.D., Frank Stokes (Chairman), Charles McKhann.
- Nominating and Corporate Governance Committee: Paul Kim (Financial Expert), Bruce C. Robertson, Ph.D., Frank Stokes (Chairman).
The filing contains no forward-looking guidance, risk factors, or discussion of unusual items beyond the personnel change.
Key Facts for Investor Verification
- Confirm the effective date of Ana Hooker's resignation (April 17, 2026).
- Verify the new composition of the Audit, Compensation, and Nominating and Corporate Governance Committees.
- Note that the Board size is now seven members.
- Understand that this filing contains no financial results or operational updates.